Emerging Predictive and Prognostic Factors for AML
Source: A Focus on AML: Applying the Latest Research to Individualize Therapy

Video

Now Playing...
In this on-demand Webcast, Keith W. Pratz, MD, provides expert perspective on optimal treatment of patients with acute myeloid leukemia.

Keith W. Pratz, MD, has disclosed that he has received funds for research support from AbbVie, Astellas, and Takeda Oncology.

Downloads

  • Emerging Predictive and Prognostic Factors for AML